@entity302 with @entity1654 : Relationship between type of XXXX and response to medication in a Greek population.

@entity1 @entity410 @entity2051 @entity1092 @entity1654 @entity302 @entity2049
PURPOSE: @entity302 with @entity1654 (BECTS) is considered to be the most common @entity302 . We studied the relationship between the type of @entity410 and response to medication in a Greek population. MATERIALS AND METHODS: We studied 60 neurodevelopmentally normal @entity1 diagnosed with BECTS. @entity1 were subdivided into three groups, based on type of @entity410 : Group A comprised 32 @entity1 with generalized @entity410 , Group B 19 @entity1 with focal @entity410 and Group C 9 @entity1 with focal @entity410 with secondary generalization. All @entity1 in the present study were started on an antiepileptic medication after the third @entity410 ( @entity1092 , @entity2049 , and @entity2051 ), and we studied the response to medication. RESULTS: 10 from 13 (76.92%) of @entity1 in Group A, 13 from 15 (86.66%) @entity1 in Group B, and all 6 @entity1 (100%) in Group C started @entity2049 or @entity2051 had a favorable respond. Similarly, 16 from 19 (84.2%) of @entity1 in Group A, 3 from 4 @entity1 (75%) in Group B, and 1 from 3 @entity1 (33.3%) in Group C, started @entity1092 responded well to medication. CONCLUSIONS: The majority of @entity1 responded well to the first antiepileptic treatment and had a favorable outcome, regardless of type of @entity410 . 88.3% of @entity1 became @entity410 free by 1 or 2 years after @entity410 onset. These findings are indicative that the type of @entity410 has no major effect neither in response to antiepileptic treatment or in the final outcome. Further research in a larger number of @entity1 is needed.
